Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: WFRF:(Hallböök Helene) > (2015-2019) > Hematopoietic stem ...

LIBRIS Formathandbok (Information om MARC21)

Fältnamn	Indikatorer	Metadata
000		04940naa a2200577 4500
001		oai:DiVA.org:uu-387985
003		SwePub
008		190627s2019 \| \|\|\|\|\|\|\|\|\|\|\|000 \|\|eng\|
024	7	a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3879852 URI
024	7	a https://doi.org/10.1038/s41409-018-0373-42 DOI
040		a (SwePub)uu
041		a engb eng
042		9 SwePub
072	7	a ref2 swepub-contenttype
072	7	a for2 swepub-publicationtype
100	1	a Giebel, Sebastianu Maria Sklodowska Curie Inst Canc Ctr, Gliwice Branch, Gliwice, Poland4 aut
245	1 0	a Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission :b a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
264		c 2018-11-01
264	1	b Springer Science and Business Media LLC,c 2019
338		a print2 rdacarrier
520		a Allogeneic hematopoietic stem cell transplantation (HSCT) in first complete remission is a standard of care for adult patients with Philadelphia chromosome (Ph)-negative acute lymphoblastic leukemia (ALL) and high risk of relapse. However, the stratification systems vary among study groups. Inadequate response at the level of minimal residual disease is the most commonly accepted factor indicating the need for alloHSCT. In this consensus paper on behalf of the European Working Group for Adult Acute Lymphoblastic Leukemia and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation, we summarize available evidence and reflect current clinical practice in major European study groups regarding both indications for HSCT and particular aspects of the procedure including the choice of donor, source of stem cells and conditioning. Finally, we propose recommendations for daily clinical practice as well as for planning of prospective trials.
650	7	a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Hematologi0 (SwePub)302022 hsv//swe
650	7	a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Hematology0 (SwePub)302022 hsv//eng
700	1	a Marks, David, Iu Univ Hosp Bristol Natl Hlth Serv Fdn Trust, Bristol, Avon, England4 aut
700	1	a Boissel, Nicolasu Hop St Louis, Paris, France4 aut
700	1	a Baron, Fredericu Univ Liege, CHU Sart Tilman, Liege, Belgium4 aut
700	1	a Chiaretti, Sabinau Sapienza Univ, Rome, Italy4 aut
700	1	a Ciceri, Fabiou Ist Sci San Raffaele, Milan, Italy4 aut
700	1	a Cornelissen, Jan J.u Erasmus MC, Univ Med Ctr, Canc Inst, Rotterdam, Netherlands4 aut
700	1	a Doubek, Michaelu Univ Hosp, Brno, Czech Republic4 aut
700	1	a Esteve, Jordiu Hosp Clin Barcelona, IDIBAPS, Barcelona, Spain4 aut
700	1	a Fielding, Adeleu Univ Coll London Hosp, North London Canc Network, London, England4 aut
700	1	a Foa, Robinu Sapienza Univ, Rome, Italy4 aut
700	1	a Gorin, Norbert-Claudeu EBMT Acute Leukemia Working Party Off, Paris, France;Hosp St Antoine, Paris, France4 aut
700	1	a Gokbuget, Nicolau Maria Sklodowska Curie Inst Canc Ctr, Gliwice Branch, Gliwice, Poland;Hop St Louis, Paris, France4 aut
700	1	a Hallböök, Heleneu Uppsala universitet,Hematologi4 aut0 (Swepub:uu)helehall
700	1	a Hoelzer, Dieteru Goethe Univ, Univ Hosp, Frankfurt, Germany4 aut
700	1	a Paravichnikova, Elenau Russia Federat Minist Publ Hlth, FGBU Hematol Res Ctr, Moscow, Russia4 aut
700	1	a Ribera, Josep-Mariau ICO Hosp Germans Trias & Pujol, Jose Carreras Res Inst, Badalona, Spain4 aut
700	1	a Savani, Bipinu Vanderbilt Univ, Med Ctr, Nashville, TN USA4 aut
700	1	a Rijneveld, Anita W.u Erasmus MC, Univ Med Ctr, Canc Inst, Rotterdam, Netherlands4 aut
700	1	a Schmid, Christophu Ludwig Maximilians Univ Munchen, Klinikum Augsburg, Munich, Germany4 aut
700	1	a Wartiovaara-Kautto, Ullau Helsinki Univ Hosp, Helsinki, Finland4 aut
700	1	a Mohty, Mohamadu Univ Coll London Hosp, North London Canc Network, London, England;EBMT Acute Leukemia Working Party Off, Paris, France4 aut
700	1	a Nagler, Arnonu Univ Coll London Hosp, North London Canc Network, London, England;Cha Sheba Med Ctr, Tel Hashomer, Israel4 aut
700	1	a Dombret, Herveu Hop St Louis, Paris, France4 aut
710	2	a Maria Sklodowska Curie Inst Canc Ctr, Gliwice Branch, Gliwice, Polandb Univ Hosp Bristol Natl Hlth Serv Fdn Trust, Bristol, Avon, England4 org
773	0	t Bone Marrow Transplantationd : Springer Science and Business Media LLCg 54:6, s. 798-809q 54:6<798-809x 0268-3369x 1476-5365
856	4	u https://www.nature.com/articles/s41409-018-0373-4.pdf
856	4 8	u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-387985
856	4 8	u https://doi.org/10.1038/s41409-018-0373-4

Hitta via bibliotek

Bone Marrow Transplantation (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Hitta mer i SwePub

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Klinisk medicin; och Hematologi

Artiklar i publikationen: Bone Marrow Tran ...

Av lärosätet: Uppsala universitet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se